It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2012.
2012 | Lucknow, Uttar Pradesh, India | ActiveRazz Biopharma Private Limited, a active private limited company, was established on 25 May 2012 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74120UP2012PTC050690. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shiv Magan Tewari (Director), Satish Kumar Pandey (Director). Past directors included Santosh Kumar Mishra, Abhisek Kumar Singh, Vinod Singh. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5/73 Vikas Nagar, Lucknow, Uttar Pradesh, 226022.
U74120UP2012PTC050690
050690
25 May 2012
₹1.00 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Razz Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Magan Tewari | Director | 15 Oct 2018 | Current |
| Satish Kumar Pandey | Director | 15 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Oct 2018 | Past |
| Pramod Abcsdd | Director | 15 Dec 2014 | Past |
| Pramod Abcsdd | Director | 20 May 2015 | Past |
| Pramod Abcsdd | Director | 15 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Razz Biopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.77% increase. The company also saw a substantial improvement in profitability, with a 108.73% increase in profit. The company's net worth Soared by an impressive increase of 24.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Razz Biopharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2019 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Razz Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Razz Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Razz Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Razz Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Razz Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100242736 was registered on 07 Jan 2019. was recorded as a recent event.
Progress on Shiv Magan Tewari was appointed as a Director was appointed as a Director on 15 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
Progress on Satish Kumar Pandey was appointed as a Director was appointed as a Director on 15 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
Progress on Razz Biopharma Private Limited was registered on 25 May 2012 with Roc Kanpur & aged 13 years 6 months as per MCA records. was documented.
The CIN of Razz Biopharma Private Limited is U74120UP2012PTC050690.
Razz Biopharma Private Limited is headquartered at 5/73 Vikas Nagar, Lucknow, Uttar Pradesh, 226022.
Razz Biopharma Private Limited was incorporated on 25 May 2012.
The current directors of Razz Biopharma Private Limited are
The primary industry of Razz Biopharma Private Limited is Trade.
Razz Biopharma Private Limited is unlisted.
The authorized capital of Razz Biopharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Razz Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX